Sampath SrisailamAssociate Research Director at Syngene International Limited
Currently heading, Manufacturing Sciences and Technology (MSAT), in Syngene International Limited, Bangalore, India. Earned his Ph.D. in structural biology and possesses 18+ years of experience in biopharmaceutical development. Published several publications in peer reviewed international scientific journals.
Led analytical method development and Physico-Chemical characterization for eight biosimilar molecules including the world’s first biosimilar antibody, Rituximab. Led teams in creating CMC sections of dossiers for several biosimilars. As a Quality Assurance lead, ensured appropriate quality systems in drug substance manufacturing of biosimilars and successfully completed EU-QP audits without major observations.